参与NF-kB激活的基因的种系变异与COPD和肺癌发展的风险相关。

IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Jurica Baranasic, Yasmeen Niazi, Subhayan Chattopadhyay, Lada Rumora, Lorna Ćorak, Andrea Vukić Dugac, Marko Jakopović, Miroslav Samaržija, Asta Försti, Jelena Knežević
{"title":"参与NF-kB激活的基因的种系变异与COPD和肺癌发展的风险相关。","authors":"Jurica Baranasic,&nbsp;Yasmeen Niazi,&nbsp;Subhayan Chattopadhyay,&nbsp;Lada Rumora,&nbsp;Lorna Ćorak,&nbsp;Andrea Vukić Dugac,&nbsp;Marko Jakopović,&nbsp;Miroslav Samaržija,&nbsp;Asta Försti,&nbsp;Jelena Knežević","doi":"10.2478/acph-2023-0019","DOIUrl":null,"url":null,"abstract":"<p><p>Chronic obstructive pulmonary disease (COPD) and lung cancer (LC) are closely related diseases associated with smoking history and dysregulated immune response. However, not all smokers develop the disease, indicating that genetic susceptibility could be important. Therefore, the aim of this study was to search for the potential overlapping genetic biomarkers, with a focus on single nucleotide polymorphisms (SNPs) located in the regulatory regions of immune-related genes. Additionally, the aim was to see if an identified SNP has potentially an effect on proinflamma-tory cytokine concentration in the serum of COPD patients. We extracted summary data of variants in 1511 immune-related genes from COPD and LC genome-wide association studies (GWAS) from the UK Biobank. The LC data had 203 cases, patients diagnosed with LC, and 360 938 controls, while COPD data had 1 897 cases and 359 297 controls. Assuming 1 association/gene, SNPs with a <i>p</i>-value < 3.3 × 10<sup>-5</sup> were considered statistically significantly associated with the disease. We identified seven SNPs located in different genes (<i>BAG6, BTNL2, TNF, HCP5, MICB, NCR3, ABCF1, TCF7L1</i>) to be associated with the COPD risk and two with the LC risk (<i>HLA-C, HLA-B</i>), with statistical significance. We also identified two SNPs located in the <i>IL2RA</i> gene associated with LC (rs2386841; <i>p</i> = 1.86 × 10<sup>-4</sup>) and COPD (rs11256442; <i>p</i> = 9.79 × 10<sup>-3</sup>) but with lower significance. Functional studies conducted on COPD patients showed that RNA expression of IL2RA, IFNγ and related proinflammatory cytokines in blood serum did not correlate with a specific genotype. Although results presented in this study do not fully support our hypothesis, it is worth to mention that the identified genes/SNPs that were associated with either COPD or LC risk, all were involved in the activation of the NF-κB transcription factor which is closely related to the regulation of the inflammatory response, a condition associated with both pathologies.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":"73 2","pages":"243-256"},"PeriodicalIF":2.1000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Germline variants of the genes involved in NF-kB activation are associated with the risk of COPD and lung cancer development.\",\"authors\":\"Jurica Baranasic,&nbsp;Yasmeen Niazi,&nbsp;Subhayan Chattopadhyay,&nbsp;Lada Rumora,&nbsp;Lorna Ćorak,&nbsp;Andrea Vukić Dugac,&nbsp;Marko Jakopović,&nbsp;Miroslav Samaržija,&nbsp;Asta Försti,&nbsp;Jelena Knežević\",\"doi\":\"10.2478/acph-2023-0019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Chronic obstructive pulmonary disease (COPD) and lung cancer (LC) are closely related diseases associated with smoking history and dysregulated immune response. However, not all smokers develop the disease, indicating that genetic susceptibility could be important. Therefore, the aim of this study was to search for the potential overlapping genetic biomarkers, with a focus on single nucleotide polymorphisms (SNPs) located in the regulatory regions of immune-related genes. Additionally, the aim was to see if an identified SNP has potentially an effect on proinflamma-tory cytokine concentration in the serum of COPD patients. We extracted summary data of variants in 1511 immune-related genes from COPD and LC genome-wide association studies (GWAS) from the UK Biobank. The LC data had 203 cases, patients diagnosed with LC, and 360 938 controls, while COPD data had 1 897 cases and 359 297 controls. Assuming 1 association/gene, SNPs with a <i>p</i>-value < 3.3 × 10<sup>-5</sup> were considered statistically significantly associated with the disease. We identified seven SNPs located in different genes (<i>BAG6, BTNL2, TNF, HCP5, MICB, NCR3, ABCF1, TCF7L1</i>) to be associated with the COPD risk and two with the LC risk (<i>HLA-C, HLA-B</i>), with statistical significance. We also identified two SNPs located in the <i>IL2RA</i> gene associated with LC (rs2386841; <i>p</i> = 1.86 × 10<sup>-4</sup>) and COPD (rs11256442; <i>p</i> = 9.79 × 10<sup>-3</sup>) but with lower significance. Functional studies conducted on COPD patients showed that RNA expression of IL2RA, IFNγ and related proinflammatory cytokines in blood serum did not correlate with a specific genotype. Although results presented in this study do not fully support our hypothesis, it is worth to mention that the identified genes/SNPs that were associated with either COPD or LC risk, all were involved in the activation of the NF-κB transcription factor which is closely related to the regulation of the inflammatory response, a condition associated with both pathologies.</p>\",\"PeriodicalId\":7034,\"journal\":{\"name\":\"Acta Pharmaceutica\",\"volume\":\"73 2\",\"pages\":\"243-256\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Pharmaceutica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2478/acph-2023-0019\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Pharmaceutica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2478/acph-2023-0019","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

慢性阻塞性肺疾病(COPD)和肺癌(LC)是与吸烟史和免疫反应失调密切相关的疾病。然而,并非所有吸烟者都会患上这种疾病,这表明遗传易感性可能很重要。因此,本研究的目的是寻找潜在的重叠遗传生物标志物,重点关注位于免疫相关基因调控区域的单核苷酸多态性(snp)。此外,目的是观察已鉴定的SNP是否对COPD患者血清中促炎细胞因子浓度有潜在影响。我们从英国生物银行(UK Biobank)的COPD和LC全基因组关联研究(GWAS)中提取了1511个免疫相关基因的变异汇总数据。LC数据有203例,诊断为LC的患者和360938例对照,而COPD数据有1897例和359297例对照。假设1关联/基因,认为p值< 3.3 × 10-5的snp与疾病有统计学显著相关。我们发现7个snp位于不同的基因(BAG6、BTNL2、TNF、HCP5、MICB、NCR3、ABCF1、TCF7L1)与COPD风险相关,2个snp与LC风险相关(HLA-C、HLA-B),差异均有统计学意义。我们还发现了位于与LC相关的IL2RA基因中的两个snp (rs2386841;p = 1.86 × 10-4)和COPD (rs11256442;P = 9.79 × 10-3),但显著性较低。对COPD患者进行的功能研究表明,血清中IL2RA、IFNγ及相关促炎细胞因子的RNA表达与特定基因型无关。尽管本研究的结果并不完全支持我们的假设,但值得一提的是,已确定的与COPD或LC风险相关的基因/ snp都参与了NF-κB转录因子的激活,而NF-κB转录因子与炎症反应的调节密切相关,而炎症反应与两种病理都相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Germline variants of the genes involved in NF-kB activation are associated with the risk of COPD and lung cancer development.

Chronic obstructive pulmonary disease (COPD) and lung cancer (LC) are closely related diseases associated with smoking history and dysregulated immune response. However, not all smokers develop the disease, indicating that genetic susceptibility could be important. Therefore, the aim of this study was to search for the potential overlapping genetic biomarkers, with a focus on single nucleotide polymorphisms (SNPs) located in the regulatory regions of immune-related genes. Additionally, the aim was to see if an identified SNP has potentially an effect on proinflamma-tory cytokine concentration in the serum of COPD patients. We extracted summary data of variants in 1511 immune-related genes from COPD and LC genome-wide association studies (GWAS) from the UK Biobank. The LC data had 203 cases, patients diagnosed with LC, and 360 938 controls, while COPD data had 1 897 cases and 359 297 controls. Assuming 1 association/gene, SNPs with a p-value < 3.3 × 10-5 were considered statistically significantly associated with the disease. We identified seven SNPs located in different genes (BAG6, BTNL2, TNF, HCP5, MICB, NCR3, ABCF1, TCF7L1) to be associated with the COPD risk and two with the LC risk (HLA-C, HLA-B), with statistical significance. We also identified two SNPs located in the IL2RA gene associated with LC (rs2386841; p = 1.86 × 10-4) and COPD (rs11256442; p = 9.79 × 10-3) but with lower significance. Functional studies conducted on COPD patients showed that RNA expression of IL2RA, IFNγ and related proinflammatory cytokines in blood serum did not correlate with a specific genotype. Although results presented in this study do not fully support our hypothesis, it is worth to mention that the identified genes/SNPs that were associated with either COPD or LC risk, all were involved in the activation of the NF-κB transcription factor which is closely related to the regulation of the inflammatory response, a condition associated with both pathologies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Acta Pharmaceutica
Acta Pharmaceutica PHARMACOLOGY & PHARMACY-
CiteScore
5.20
自引率
3.60%
发文量
20
审稿时长
>12 weeks
期刊介绍: AP is an international, multidisciplinary journal devoted to pharmaceutical and allied sciences and contains articles predominantly on core biomedical and health subjects. The aim of AP is to increase the impact of pharmaceutical research in academia, industry and laboratories. With strong emphasis on quality and originality, AP publishes reports from the discovery of a drug up to clinical practice. Topics covered are: analytics, biochemistry, biopharmaceutics, biotechnology, cell biology, cell cultures, clinical pharmacy, drug design, drug delivery, drug disposition, drug stability, gene technology, medicine (including diagnostics and therapy), medicinal chemistry, metabolism, molecular modeling, pharmacology (clinical and animal), peptide and protein chemistry, pharmacognosy, pharmacoepidemiology, pharmacoeconomics, pharmacodynamics and pharmacokinetics, protein design, radiopharmaceuticals, and toxicology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信